Sign in
CompletedNo phase

Comparison of the SUNRISE© Device With Ventilatory Polygraphy for the Diagnosis of Obstructive Sleep Apnea Hypopnea Syndrome: Collection of Preliminary Data

Key facts

Who runs it
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
37 people enrolled
Started
19 Jun 2024
Ended
28 Feb 2025
Type of study
Observational
Treatments tested
  • SUNRISE© device
Record updated
29 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patient aged 18 or over
  • Patient with a smartphone (Android or iOS) with Bluetooth and Internet connection and able to use the mobile application associated with the Sunrise© medical device
  • Patient having a scheduled exploration by ventilatory polygraphy
  • Non-opposition to participation in the research

Who cannot take part

  • Patient suffering from a psychiatric pathology or with a history of behavioral disorders
  • Patient already treated for OSAHS
  • Patient refusing to cut his beard (if too abundant to wear the Sunrise© device)
  • Patient suffering from a pathology affecting the rotation of the condyle in the temporomandibular joint
  • Patient deprived of liberty by judicial or administrative decision
  • Patients under court protection or legal guardianship

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Additional data on screening for obstructive sleep apnea/hypopnea syndrome (OSAHS) in patients with co-morbidities, such as diabetics and those with chronic respiratory diseases would enable current recommendations to evolve, with a view to promoting the widespread use of simplified techniques for OSAHS screening, particularly in patients with cardiorespiratory co-morbidities.

Read full original descriptionShow less

The primary objective of this observational multicentric pilot study is to compare the performance of the Sunrise® medical device with that of ventilatory polygraphy as part of routine screening for OSAHS in diabetic patients followed up in the diabetology department of the Strasbourg University Hospital, and in patients followed up in the pneumology consultation department of Mulhouse Hospital (GHRMSA).

The group in the trial

  • Suspected OSAHS

    Treatment: SUNRISE© device

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 May 2026